| Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes R Gao, S Bai, YC Henderson, Y Lin, A Schalck, Y Yan, T Kumar, M Hu, ... Nature biotechnology 39 (5), 599-608, 2021 | 187 | 2021 |
| Advancing cancer research and medicine with single-cell genomics B Lim, Y Lin, N Navin Cancer cell 37 (4), 456-470, 2020 | 147 | 2020 |
| Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells J Gong, Y Lin, H Zhang, C Liu, Z Cheng, X Yang, J Zhang, Y Xiao, N Sang, ... Cell death & disease 11 (4), 267, 2020 | 103 | 2020 |
| Telomere dysfunction activates YAP1 to drive tissue inflammation D Chakravarti, B Hu, X Mao, A Rashid, J Li, J Li, W Liao, EM Whitley, ... Nature communications 11 (1), 4766, 2020 | 37 | 2020 |
| ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway Y Li, L Tao, Z Zuo, Y Zhou, X Qian, Y Lin, H Jie, C Liu, Z Li, H Zhang, ... Cancer letters 454, 179-190, 2019 | 33 | 2019 |
| Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation C Liu, L Wang, X Liu, Y Tan, L Tao, Y Xiao, P Deng, H Wang, Q Deng, ... Theranostics 11 (6), 2966, 2021 | 23 | 2021 |
| LC‑MS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells W Peng, S Tan, Y Xu, L Wang, D Qiu, C Cheng, Y Lin, C Liu, Z Li, Y Li, ... Oncology Reports 40 (2), 1026-1034, 2018 | 19 | 2018 |
| Cocaine modifies brain lipidome in mice Y Lin, H Gu, L Jiang, W Xu, C Liu, Y Li, X Qian, D Li, Z Li, J Hu, H Zhang, ... Molecular and Cellular Neuroscience 85, 29-44, 2017 | 17 | 2017 |
| Remodeling of brain lipidome in methamphetamine-sensitized mice L Jiang, H Gu, Y Lin, W Xu, R Zhu, J Kong, L Luo, H Long, B Liu, B Chen, ... Toxicology Letters 279, 67-76, 2017 | 17 | 2017 |
| Integrative clinical and genomic characterization of MTAP-deficient metastatic urothelial cancer O Alhalabi, Y Zhu, A Hamza, W Qiao, Y Lin, RM Wang, AY Shah, ... European Urology Oncology, 2021 | 12 | 2021 |
| 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice Y Li, C Wang, D Li, P Deng, X Shao, J Hu, C Liu, H Jie, Y Lin, Z Li, X Qian, ... Oncology reports 38 (5), 3044-3054, 2017 | 12 | 2017 |
| Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment Y Li, X Qian, Y Lin, L Tao, Z Zuo, H Zhang, S Yang, X Cen, Y Zhao Oncology Reports 46 (5), 1-15, 2021 | 3 | 2021 |
| The unique pancreatic stellate cell gene expression signatures are associated with the progression from acute to chronic pancreatitis C Hu, L Yin, Z Chen, RT Waldron, A Lugea, Y Lin, X Zhai, L Wen, YP Han, ... Computational and Structural Biotechnology Journal 19, 6375-6385, 2021 | 3 | 2021 |
| Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma L Pang, M Dunterman, W Xuan, A Gonzalez, Y Lin, WH Hsu, F Khan, ... Cell reports 42 (2), 2023 | 1 | 2023 |
| Identification of immune subtypes of lung squamous cell carcinoma by integrative genome-scale analysis L Yin, W Zhang, D Pu, X Zhai, Y Lin, Q Wu, T Chang, J Hu, Y Li, Q Zhou Frontiers in oncology 11, 778549, 2022 | 1 | 2022 |
| Reprogramming of the preinvasive breast microenvironment identified by spatial nucleus barcoding K Wang, Z Xiao, Y Lin, R Wei, J Ye, R Ye, M Hu, S Bai, E Sei, ... Cancer Research 83 (7_Supplement), 76-76, 2023 | | 2023 |
| Decoding the natural biology of triple-negative breast cancer and response to chemotherapy by single-cell transcriptomics T Kumar, Y Lin, Y Yan, S Bai, J Li, T Tran, M Hu, E Ravenberg, M Rauch, ... Cancer Research 83 (7_Supplement), 2147-2147, 2023 | | 2023 |
| Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib X Zhai, T Wang, Y Lin, J Zhang, Y Wang, W Wang, Q Zhou, D Zhu Frontiers in Oncology 13, 2023 | | 2023 |
| Abstract PO-020: Inferring copy number substructure from single-cell transcriptomics in human tumors with CopyKat R Gao, S Bai, H Ying, Y Lin, T Seth, M Hu, E Sei, A Davis, F Wang, ... Cancer Research 80 (21_Supplement), PO-020-PO-020, 2020 | | 2020 |
| Characterization of the Gas6/TAM Pathway as a Potential Therapeutic Target and its Immune Landscape L Li, Q Zhou, X Zhai, D Pu, R Wang, J Zhang, Y Lin, Y Wang Frontiers in Oncology 13, 1677, 0 | | |
Nicholas NavinMD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
Nicholas NavinMD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证